CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service
Oncologists will be able to submit claims to payers using a Category III CPT code, paving the way for wider adoption of precision treatment options.
CureMatch, Inc., a leader in precision medicine support for oncology, is pleased to announce that the American Medical Association (AMA) has issued the new Current Procedural Terminology (CPT®) Category III code 0794T for the therapy matching and scoring service CureMatch offers (“Patient-specific, assistive, rules-based algorithm for ranking pharmaco-oncologic treatment options based on the patient’s tumor-specific cancer marker information obtained from prior molecular pathology, immunohistochemical, or other pathology results which have been previously interpreted and reported separately”). The AMA published this code on January 1, 2023, and it will be effective July 1, 2023, which will allow oncologists to track the use of CureMatch’s groundbreaking therapy matching system and submit for reimbursement.